Top therapeutic areas by global pharmaceutical sales 2023

This statistic depicts the top 10 therapeutic areas by global pharmaceutical sales in 2023. In that year, global pharmaceutical sales in the area of mental health were 36 billion U.S. dollars. 

Top therapeutic classes and drugs

Oncologics, anti-diabetics and immunology were the top global therapeutic areas based on revenues in 2023. In oncologic research and development, drugs for non-small cell lung cancer and breast cancer are among the leading diseases. On the other hand, mental health treatments generated about 36 billion dollars of revenue worldwide. One such drug is Cymbalta, manufactured by Eli Lilly and used to treat major depressive disorder and generalized anxiety disorder.

One of Bristol-Myers Squibb’s most profitable medications was Abilify, a neurology product and blockbuster for many years. Aripiprazole, marketed as Abilify, is used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, among other disorders. Bristol-Myers Squibb’s neuroscience program focuses on the development of therapeutic regimens for disorders that impact the brain and nervous systems.